IL2RA and prostate cancer: Apart from downregulating CD69 and CD25 expression, CuIIb also induced cell cycle arrest in S and G2/M phases in activated lymphocytes, which is in agreement with the previous study that this same agent caused a similar cell cycle arrest in human prostate cancer cells [18].